{
    "2018-01-02": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Notable Tuesday Option Activity: FDX, WM, ABBV",
                "features": {
                    "keywords": [
                        "Option Activity",
                        "FDX",
                        "WM",
                        "ABBV"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "transportation",
                        "waste management",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "The Zacks Analyst Blog Highlights: Johnson and Johnson, AbbVie, Roche's, AstraZeneca and Novo-Nordisk A/S",
                "features": {
                    "keywords": [
                        "Zacks Analyst Blog",
                        "Johnson and Johnson",
                        "AbbVie",
                        "Roche",
                        "AstraZeneca",
                        "Novo-Nordisk A/S"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "3 Best Big Pharma Stocks to Buy for 2018",
                "features": {
                    "keywords": [
                        "Best Big Pharma Stocks",
                        "Buy",
                        "2018"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "The Zacks Analyst Blog Highlights: Johnson and Johnson, AbbVie, Roche's, AstraZeneca and Novo-Nordisk A/S",
                "features": {
                    "keywords": [
                        "Zacks Analyst Blog",
                        "Johnson and Johnson",
                        "AbbVie",
                        "Roche",
                        "AstraZeneca",
                        "Novo-Nordisk A/S"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}